180 related articles for article (PubMed ID: 38627156)
1. Neutrophil-to-Lymphocyte Ratio and Risk of Nodal Metastasis in Early-Stage Lung Adenocarcinoma: A Brief Report From a Multicentric Analysis.
Gallina FT; Chiappetta M; Tajè R; Forcella D; Sassorossi C; Congedo MT; Evangelista J; Sperduti I; Lococo F; Cappuzzo F; Melis E; Margaritora S; Facciolo F
Clin Lung Cancer; 2024 Jun; 25(4):e196-e200.e1. PubMed ID: 38627156
[No Abstract] [Full Text] [Related]
2. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract][Full Text] [Related]
3. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
4. Association of intra-tumoral tumour-infiltrating lymphocytes and neutrophil-to-lymphocyte ratio is an independent prognostic factor in non-small cell lung cancer.
Dirican N; Karakaya YA; Gunes S; Daloglu FT; Dirican A
Clin Respir J; 2017 Nov; 11(6):789-796. PubMed ID: 26619201
[TBL] [Abstract][Full Text] [Related]
5. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis?
Unal D; Eroglu C; Kurtul N; Oguz A; Tasdemir A
Asian Pac J Cancer Prev; 2013; 14(9):5237-42. PubMed ID: 24175807
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Prognostic Value of "Neutrophil to Lymphocyte Ratio" and "Prognostic Nutritional Index" as a Sytemic Inflammatory Marker in Non-small Cell Lung Cancer.
Kos FT; Hocazade C; Kos M; Uncu D; Karakas E; Dogan M; Uncu HG; Ozdemir N; Zengin N
Asian Pac J Cancer Prev; 2015; 16(9):3997-4002. PubMed ID: 25987075
[TBL] [Abstract][Full Text] [Related]
7. Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ratio in pathological stage IIIA (N2-positive) non-small cell lung cancer patients.
Tsukioka T; Izumi N; Mizuguchi S; Kyukwang C; Komatsu H; Toda M; Hara K; Miyamoto H; Nishiyama N
Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):716-722. PubMed ID: 30105630
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK
Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer.
Huang C; Yue J; Li Z; Li N; Zhao J; Qi D
Tumour Biol; 2015 Sep; 36(10):7581-9. PubMed ID: 25921282
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity.
Wang Y; Jing L; Wang G
J Cardiothorac Surg; 2020 Aug; 15(1):121. PubMed ID: 32782020
[TBL] [Abstract][Full Text] [Related]
12. Implication of total tumor size on the prognosis of patients with clinical stage IA lung adenocarcinomas appearing as part-solid nodules: Does only the solid portion size matter?
Kim H; Goo JM; Suh YJ; Park CM; Kim YT
Eur Radiol; 2019 Mar; 29(3):1586-1594. PubMed ID: 30132107
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
[TBL] [Abstract][Full Text] [Related]
15. ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma.
Gallina FT; Tajè R; Letizia Cecere F; Forcella D; Landi L; Minuti G; Fusco F; Buglioni S; Visca P; Melis E; Sperduti I; Ciliberto G; Cappuzzo F; Facciolo F
Lung Cancer; 2023 Jun; 180():107215. PubMed ID: 37126920
[TBL] [Abstract][Full Text] [Related]
16. Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer.
Shimizu K; Okita R; Saisho S; Maeda A; Nojima Y; Nakata M
World J Surg Oncol; 2015 Sep; 13():291. PubMed ID: 26424708
[TBL] [Abstract][Full Text] [Related]
17. Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis.
Yuan Y; Ma G; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):743-749. PubMed ID: 29392402
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non-Small Cell Lung Cancer Treated with Combined Modality Therapy.
Scilla KA; Bentzen SM; Lam VK; Mohindra P; Nichols EM; Vyfhuis MA; Bhooshan N; Feigenberg SJ; Edelman MJ; Feliciano JL
Oncologist; 2017 Jun; 22(6):737-742. PubMed ID: 28533476
[TBL] [Abstract][Full Text] [Related]
19. Combining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma Patients.
Wang W; Bian C; Xia D; He JX; Hai P; Zhao R; Wang YY
Biomed Res Int; 2017; 2017():8076384. PubMed ID: 28642881
[TBL] [Abstract][Full Text] [Related]
20. Hematologic Markers of Lung Metastasis in Stage IV Colorectal Cancer.
Abu-Shawer M; Abu-Shawer O; Souleiman M; Akkawi M; Alshakhatreh O; Altamimi T; Al-Omari A; Al-Hussaini M
J Gastrointest Cancer; 2019 Sep; 50(3):428-433. PubMed ID: 29589285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
